Clinical Trials Logo
  1. Home
  2. Infant, Newborn, Diseases
  3. NCT00008736
  4. Details
NCT00008736 Clinical Trial

Electrogastrography (EGC) in Premature Infants With Feeding Intolerance

Infant, Newborn, Diseases Clinical Trial

Official title:
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00008736
Other study ID # NCRR-M01RR00240-1724
Secondary ID
Status Completed
Phase Phase 2
First received January 16, 2001
Last updated June 23, 2005

Study information
Verified date December 2003
Source National Center for Research Resources (NCRR)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.

Recruitment information / eligibility
Status Completed
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A to 1 Month
Eligibility Inclusion:

Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation

Study Design

Allocation: Non-Randomized, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Drug:
• metoclopramide

Locations
Country Name City State
United States Children's Hospital of Philadelphia Philadelphia Pennsylvania

Sponsors (2)
Lead Sponsor Collaborator
National Center for Research Resources (NCRR) Children's Hospital of Philadelphia

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05936112 - Quantification of Fecal Calprotectin Concentration Difference Between Infants Aged Under 4 Months Old Suffering From Functional Gastrointestinal Disorders (FGID) and Infants Aged Under 4 Months Old Free From Disorders : a Transversal Case-control Monocentric Study N/A
Not yet recruiting NCT05954975 - Baby Sickness Evaluation
Completed NCT02968628 - Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
Not yet recruiting NCT00994149 - Diazoxide In the Management Of Hypoglycemic Neonates Phase 2/Phase 3
Completed NCT03571932 - Assessment of Family Planning and Immunization Service Integration in Liberia
Completed NCT02865772 - Lamellar Body Counts on Gastric Aspirate in Healthy Term Newborns N/A
Completed NCT03535311 - Estimating Insertion Length of Umbilical Catheters in Newborn Infants
Completed NCT00477594 - Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia Phase 2
Recruiting NCT06139809 - Noninvasive Positive Pressure Ventilation During Neonatal Nasal Intubation N/A
Recruiting NCT03162653 - Effect of Allopurinol for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome Phase 3
Not yet recruiting NCT06267508 - Increasing Neonatal HIV Test and Treat to Maximize the Long-Term Impact on Infant Health and Novel Infant Antiretroviral Treatment
Completed NCT02701920 - HeartLight: Heart Rate Monitoring for Newborn Resuscitation
Completed NCT01124331 - Appropriate Oxygen Levels for Extremely Preterm Infants: a Prospective Meta-analysis N/A
Active, not recruiting NCT04354220 - Capnography Monitoring in Ventilated Children
Recruiting NCT05793723 - Long-term Respiratory Complications in Infants With Perinatal COVID-19
Completed NCT03404284 - Assessment of Family Planning and Immunization Service Integration in Malawi N/A
Completed NCT01954056 - Hydrocortisone for Term Hypotension Phase 3
Not yet recruiting NCT06255886 - Treatment of Gastroesophageal Reflux Disease in Infants Phase 4
Completed NCT02434380 - Effect of Vitamin D Replacement on Maternal and Neonatal Outcomes Phase 3
Completed NCT00607373 - Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia Phase 3